This inventor holds 2 USPTO granted patents and 3 published patent applications. Top assignee: Galderma Holding Sa. Active years: 2022-2026.
Company Filing History:
Years Active: 2022-2026
Title: Christophe Piketty: Innovator in Dermatological Treatments
Introduction
Christophe Piketty is a notable inventor based in Montargis, France. He has made significant contributions to the field of dermatology, particularly in the treatment of skin conditions. His innovative approach has led to the development of a patent that addresses a common yet challenging issue faced by patients.
Latest Patents
Christophe Piketty holds a patent for the "Treatment of skin lesions and pruritus in prurigo nodularis patients." This patent discloses methods for selectively treating pruritus in subjects suffering from chronic prurigo, including prurigo nodularis. The patent also includes pharmaceutical compositions designed for the treatment of pruritus in these patients. Notably, it discusses the uses of nemolizumab or equivalent compounds in the manufacture of a medicament aimed at alleviating pruritus in affected individuals. He has 1 patent to his name.
Career Highlights
Christophe Piketty is associated with Galderma Holding SA, a company renowned for its focus on dermatological products and treatments. His work at Galderma has allowed him to contribute to advancements in skin health and patient care.
Collaborations
Due to space constraints, the collaborations section will be omitted.
Conclusion
Christophe Piketty's innovative work in dermatology, particularly through his patent for treating pruritus in prurigo nodularis patients, showcases his commitment to improving patient outcomes. His contributions are significant in the ongoing quest for effective dermatological treatments.